Hossein Taghizadeh

Hossein Taghizadeh, MSc PhD, is a resident physician in hematology and oncology at the Department of Internal Medicine 1, St. Pölten University Hospital, and affiliated with Karl Landsteiner Private University of Health Sciences. He holds a PhD in Oncology from the Medical University of Vienna and a Master’s in Molecular Oncology from Centro de Estudios Biosanitarios, Madrid. He conducts postdoctoral research at the MUW Center for Cancer Research and teaches at both Karl Landsteiner and Medical University of Vienna.

• Education: Medical degree, PhD in Oncology (MUW), MSc in Molecular Oncology (Madrid)
• Current Roles: Resident in Hematology & Oncology, Postdoc Researcher, Graduate Supervisor, Clinical Lead (Gastrointestinal Oncology Outpatient Clinic)
• Future Plans: Awaits specialization exam in 2023; has submitted habilitation thesis to MUW.

Dr. Taghizadeh's research focuses on molecular oncology and targeted therapies in solid tumors, particularly gastrointestinal cancers. His work emphasizes real-world clinical data, molecular profiling, and personalized treatment strategies. He investigates biomarkers in colorectal, pancreatic, biliary, and lung cancers, with a strong focus on improving survival through precision medicine.

His recent publications show a consistent trend in evaluating targeted therapies, immunotherapy, and systemic treatment protocols across biliary tract, pancreatic, and colorectal cancers. He frequently uses retrospective real-world data and contributes to national expert consensus statements, highlighting his growing influence in Austrian oncology.

Dr. Taghizadeh actively supervises graduate students and teaches at two universities, emphasizing the importance of training future physicians. He serves as a reviewer for multiple journals, further demonstrating his academic engagement.

• Principal Investigator of multiple research projects on pancreatic and biliary cancers
• Active in clinical research at St. Pölten University Hospital
• Member of research teams at MUW Center for Cancer Research